Features

The annual Drug Delivery to the Lungs meeting returns to the Edinburgh International Conference Centre (EICC) December 6-8. DDL 2022 attracted a total of more than 1,000 delegates in person and online, and DDL 2023 is also expected to draw a large crowd, says organizing committee member Michelle Dawson. For the first time, DDL will take over the entire EICC, providing … [Read more...] about Previewing DDL 2023

The International Society for Aerosols in Medicine (ISAM) welcomed more than 260 attendees to its 2023 biannual congress August 26-30 in Saarbrücken, Germany, reports organizing committee member Claus-Michael Lehr of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). In addition to the scientific program, the meeting included 6 workshops, 21 … [Read more...] about ISAM Congress 2023

Intertek Pharmaceutical Services Commercial Director Chris Vernall on how the new FDA nasal bioequivalence guidances support an in vitro only bioequivalence pathway and continue wider industry focus on evolving analytical and in silico tools for generic OINDP testing What is the main difference in in-vitro bioequivalence (IVBE) recommendations between the May 2023 … [Read more...] about Q&A with Intertek’s Chris Vernall on in-vitro only BE and the new nasal bioequivalence guidances

At RDD Europe 2023, which took place May 2-5 in Antibes, France, Richard Dalby noted in his opening remarks that approximately 420 inhaled and nasal drug delivery experts from 28 countries were attending the conference in person with another 20 or so delegates attending virtually. Noting that 2023 was the first in-person version of RDD Europe since 2019, he welcomed … [Read more...] about RDD Europe 2023 highlighted sustainability, nasal drug delivery, and biologics

RDD Europe 2023, organized by RDD Online and Aptar Pharma, returns to Antibes, France, May 2-5 at the Palais des Congrès Antipolis. Richard Dalby of RDD Online says that conference center (previously called the Palais des Congrès Antibes) proved popular with attendees at RDD Europe 2015 and 2017, which took place at the same venue. Dalby expects that attendance will … [Read more...] about RDD Europe 2023 returns to Antibes

In its return to the Edinburgh International Conference Centre after two years of online-only meetings, the Drug Delivery to the Lungs conference looked toward the future, focusing on scientific and technical innovations that will influence inhaled and nasal drug development for years to come. The meeting drew a record crowd, with approximately 130 virtual … [Read more...] about DDL 2022 looked to the future of OINDP development

Copley Scientific CEO Mark Copley answers questions about the importance of the test environment for OIP testing Why is the test environment so important for inhaler testing? Due to a broad range of factors, including interaction between formulation, device, and patient, orally inhaled product (OIP) testing is naturally more variable than testing for simple … [Read more...] about Q&A with Mark Copley: Reducing Inhaler Testing Variability Through Test Environment Control

Registration is open for DDL 2022, which will be the first in-person Drug Delivery to the Lungs meeting since the beginning of the COVID-19 pandemic. The meeting will take place December 7-9 and is expected to attract hundreds of delegates to the Edinburgh International Conference Centre (EICC), with additional delegates able to access the programming online in real … [Read more...] about OINDP specialists to gather in Edinburgh and online for DDL 2022